Home

XBiotech, Inc. (XBIT)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about XBiotech, Inc. (XBIT)

Go deeper and ask any question about XBIT

Company Performance

Current Price

as of Sep 13, 2024

$7.06

P/E Ratio

N/A

Market Cap

$215.07M

Description

XBiotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic antibodies. Its product pipeline includes oncology, infectious diseases, dermatology and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.

Metrics

Overview

  • HQAustin, TX
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerXBIT
  • Price$7.06+3.52%

Trading Information

  • Market Cap$215.07M
  • Float64.87%
  • Average Daily Volume (1m)52,460
  • Average Daily Volume (3m)123,901
  • EPS-$1.15

Company

  • RevenueN/A
  • Rev Growth (1yr)N/A
  • Net Income-$13.01M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$14.53M
  • EV-$21.99M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
Documents